Compare Citatah Tbk. (CTTH) vs Kimia Farma Tbk (KAEF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citatah Tbk. vs Kimia Farma Tbk — how do they compare? Citatah Tbk. trades at Rp109 (market cap 136.62B, 3.38M 24h volume), while Kimia Farma Tbk trades at Rp454 (market cap 2.53T, 414.5K 24h volume). The key difference: Kimia Farma Tbk is far larger — about 18.5× Citatah Tbk.'s market cap, and Citatah Tbk. is more actively traded (3.38M versus 414.5K). Which is the better fit depends on your goals.
| CTTH | KAEF | |
|---|---|---|
Market Cap | 136.62B | 2.53T |
Volume | 3.38M | 414.5K |
Lot | 33.83K | 4.15K |
Turnover | 370.83M | 187M |
Average Price | 109.63 | 451.15 |
Value | 370.83M | 187M |
Indicative Equilibrium Price | 109 | 454 |
Indicative Equilibrium Volume | 1.66K | 50 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citatah Tbk.
Citatah was the first private company to develop Indonesia’s marble resources, and has been involved in the extraction and processing of marble for twenty five years. Established in 1974, the company began mining began mining beige marble from its quarry near Bandung, and subsequently achieved a dominant market position for its material in Indonesia. In January 1996, the company acquired a 90% shareholding in PT Quarindah Ekamaju Marmer, a marble company with quarries and a modern processing plant in Singkep, South Sulawesi. Soon after, Citatah acquired a license to mine an additional quarry at Pingkep, which increased the company’s potential raw material output to 60,000 cubic meters a year. In 1998, Citatah opened its Special Projects Centre at Karawang, East of Jakarta. This processing facility comprises a marble and granite slab cutting and polishing factory alongside a design and fabrication factory, which houses a variety of specialist cutting, shaping and finishing machinery. The special projects center is considered to be one of the most modern and complete stone fabrication factories in the world. In 1999, Citatah began excavation at a 50 hectare quarry site in West Timur. This new quarry produces a unique and attractive beige marble which will become the company’s principal export product for the new millennium. Work has already begun on the necessary infrastructure to fully develop the quarry site. An international sales network of agents and representatives supports Citatah’s production, and a majority owned sales subsidiary, UGMC Inc., in California, USA. In 1999, three quarters of the company’s production was exported, mainly to markets in the Asia Pacific region and the US, an overseas revenues accounted for over 90% of Total Sales, and in 2000, 75% of Total Sales.
Read more on CTTH →About Kimia Farma Tbk
PT Kimia Farma Tbk (the Company) was established based on the Notarial Deed No. 18 dated August 16, 1971, as amended by Notarial Deed No. 18 dated October 11, 1971 of Soelaeman Ardjasasmita, S.H., under its original name Perusahaaan Negara Farmasi dan Alat Kesehatan Bhinneka Kimia Farma (PN Farmasi Kimia Farma). PN Farmasi Kimia Farma consist of : Badan Pimpinan Umum Perusahaan-perusahaan Negara Farmasi dan Alat Kesehatan (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Radja Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Nakula Farma (established 1961) Perusahaan Negara Farmasi Alat Kesehatan Bhinneka Kimia Farma (established 1961)PN Farmasi Kimia Farma has been changed to PT Kimia Farma (Persero) Tbk based on notarial deed dated October 11, 1971. The company’s article of association has been amended from time to time, the latest of which was covered by notarial deed dated Sept 22, 2000 by Wahjono H, SH concerning Right Issue (as public company). The Company operates 210 apoteks, 6 units production and 40 branches pharmacy wholesale. The company’s share will be listed in BEJ and BES.
Read more on KAEF →
